arrow_back Back to App

Limiting Funds for Agency and FDA Buildings in 2024

This bill aims to cap spending on buildings and facilities for Related Agencies and the Food and Drug Administration (FDA) in fiscal year 2024. This means less public money will be allocated for these purposes, potentially impacting the infrastructure development of these institutions. For citizens, this could mean that some construction or modernization projects within these agencies might be halted or delayed.
Key points
The bill limits the maximum amount that can be spent on Related Agency and FDA buildings and facilities to $11,788,000 in 2024.
This could affect the ability of these agencies to expand or maintain their infrastructure, potentially impacting their operations.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_2296
Sponsor: Rep. Biggs, Andy [R-AZ-5]
Process start date: 2023-03-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, Buildings and Facilities for fiscal year 2024.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_2296.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-29.

What are the main provisions?

Key points include:

  • The bill limits the maximum amount that can be spent on Related Agency and FDA buildings and facilities to $11,788,000 in 2024.
  • This could affect the ability of these agencies to expand or maintain their infrastructure, potentially impacting their operations.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Biggs, Andy [R-AZ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Public Investments Health